Unlocking Bioinformatics-Driven Insights Across FMCG Sectors with Scalable Bioinformatics Solutions
The future of innovation in life sciences lies in transforming complex biological data into actionable insights. From microbiome-based therapeutics to AI-enabled product innovation in health and nutrition, organizations today demand scalable and intelligent bioinformatics workflows. Excelra bridges science and data by providing domain-centric, AI-driven solutions that accelerate discovery, development, and decision-making across industries.
Whether you’re expanding a probiotic pipeline, identifying biomarkers, optimizing strain design, or repositioning drug candidates, Excelra’s expertise ensures faster R&D, data-driven insights, and better outcomes.
The result? Smarter, faster, and more sustainable innovation in crop and livestock genetics.
Key Data Challenges Across Industries
Bottlenecks in Omics Data Integration
High-Volume, Multi-Source Data Complexity Whether from WGS, metabolomics, clinical literature, or microbiome sequencing, integrating and interpreting large, diverse datasets remains a bottleneck.
AI-Driven Decision Support
Need for AI-Driven Decision Support From consumer products to pharmaceuticals, fast, data-backed decision-making is critical. AI/ML pipelines are essential for predictive insights and prioritization.
Regulatory and R&D Timelines
Regulatory and R&D Timelines Complying with regulatory standards while reducing time-to-decision across preclinical and commercial development requires scalable, validated workflows.
Empowering FMCG Innovation with Bioinformatics and AI-Driven Insights
At Excelra, we help FMCG brands unlock the full potential of their ingredients, formulations, and R&D pipelines through advanced bioinformatics, AI-enabled analytics, and data-driven discovery.From repositioning probiotics for neuro-gastro health and streamlining microbiome strain engineering, to identifying novel biomarkers, prioritizing molecular targets, and uncovering mechanisms of action for consumer products, we offer end-to-end solutions that accelerate product innovation.
It's time to make moves
Our scalable frameworks support faster decision-making, improve traceability, and enhance scientific substantiation across functional foods, nutraceuticals, dermatology, and personal care.
Excelra’s Bioinformatics Solutions
Excelra acquires BISC Global, creating an international bioinformatics powerhouse with an industry-leading platform and service offering.
Why Excelra?
Domain Expertise
Deep domain knowledge in bioinformatics, cheminformatics, and life sciences data science
Proven Impact
Proven success across pharma, FMCG, nutraceuticals, and consumer healthcare
Scalable Solutions
Scalable solutions for multi-omics, microbiome, and variant analysis
AI Integration
Expertise in AI/ML integration with science-first interpretation
Excelra’s Bioinformatics Use Cases at a Glance
Probiotic Repositioning for Autism Spectrum Disorder (ASD)
A UK-based microbiome CRO aimed to explore additional indications for Lactobacillus rhamnosus (HN001). Excelra mapped behavioral and gastrointestinal symptom overlaps in ASD through literature and pathway-level data integration, leading to:
- Indication expansion into ASD
- A roadmap for further clinical validation
Biomarker Discovery for Cell Line Lineage Mapping
A Belgium-based food and beverage company sought a quality control method to link chicken cell lines to embryonic origins. Excelra provided a PCR-based approach that enabled:
- Faster, cost-effective QC
- Improved traceability over WGS
Microbiome & Strain Engineering for Health Solutions
A global nutrition firm needed bioinformatics pipelines for strain validation across ONT and Illumina data. Excelra designed and automated workflows that allowed:
- Plasmid construct validation
- Strain prioritization for biomolecule synthesis (e.g., Vitamin A)
- Faster microbiome R&D cycles
AI-Driven Dermatology Drug Repositioning
A Japanese pharmaceutical firm explored drugs linked to wrinkle-related phenotypes. Excelra’s literature mining and phenotypic pathway mapping helped identify:
- 186 assets, 10 shortlisted for preclinical studies
- AI-informed dermatology R&D
Hair Dye Mechanism of Action Analysis
A European consumer product brand wanted to understand how a hair dye molecule binds to keratin. Through bioinformatics modeling, Excelra provided:
- Mechanistic clarity
- Preclinical decision support
Target Prioritization for FMCG R&D
A global personal care brand lacked a scalable framework for biological target selection. Excelra developed:
- A transparent, AI-powered scoring system
- Dashboards for multi-parameter prioritization
Butyrate Mechanism Mapping in Gut Health
A nutraceuticals leader needed mechanistic insights into Butyrate. Excelra deployed NLP models and pathway mapping to:
- Identify over 200 protein targets
- Cluster targets under health benefits like inflammation, gut-brain axis, and barrier repair
Ready to get more from data?
Tell us about your objectives. We’ll help get you there.
"*" indicates required fields
